Published in Hum Immunol on February 01, 2003
Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res (2003) 1.32
Genetics of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.25
Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One (2011) 1.04
Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum Immunol (2006) 1.00
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. Haematologica (2011) 0.89
Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes Metab (2009) 0.86
Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody. Clin Exp Immunol (2009) 0.85
Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia. Hum Immunol (2009) 0.78
Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients. Clin Vaccine Immunol (2007) 0.77
-383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study. Rheumatol Int (2011) 0.75
Association of TNF-α 308 G/A Polymorphism With Type 2 Diabetes: A Case-Control Study in the Iranian Kurdish Ethnic Group. Osong Public Health Res Perspect (2015) 0.75
The -383A>C TNFRI polymorphism is associated with soluble levels and clinical activity in rheumatoid arthritis. Rheumatol Int (2009) 0.75
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet (2008) 9.39
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Mutations of optineurin in amyotrophic lateral sclerosis. Nature (2010) 4.54
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int (2008) 2.47
The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res (2011) 2.19
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol (2010) 2.06
Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res (2008) 2.02
Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol (2009) 2.00
Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol (2005) 1.70
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol (2012) 1.68
Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet (2007) 1.62
Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes Care (2003) 1.61
Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain (2004) 1.59
Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology (2009) 1.55
Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism. Brain (2013) 1.53
Bilateral pallidal deep brain stimulation in primary Meige syndrome. Parkinsonism Relat Disord (2010) 1.51
Decreased plasma extracellular superoxide dismutase level in patients with vasospastic angina. Atherosclerosis (2006) 1.47
Eosinophil count is positively correlated with coronary artery calcification. Hypertens Res (2011) 1.47
Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant (2004) 1.46
Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. J Neurol Neurosurg Psychiatry (2013) 1.45
A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes. Hypertens Res (2013) 1.43
Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus. J Hypertens (2015) 1.41
Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Intern Med (2003) 1.41
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature (2011) 1.41
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism (2008) 1.39
Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet (2009) 1.38
Experimental hyperhomocysteinemia impairs coronary flow velocity reserve. Int J Cardiol (2005) 1.38
Increased variability of axonal excitability in amyotrophic lateral sclerosis. Clin Neurophysiol (2013) 1.38
Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med (2007) 1.33
Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA (2003) 1.29
Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 1.29
Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol (2011) 1.29
Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis (2011) 1.27
The anatomical basis of dystonia: current view using neuroimaging. Mov Disord (2013) 1.27
Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem (2008) 1.24
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord (2009) 1.22
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta (2004) 1.20
Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis (2009) 1.18
Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J (2008) 1.18
Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J Neurol (2012) 1.17
Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors (2004) 1.16
SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet (2007) 1.12
Serum prostate-specific antigen levels in men with type 2 diabetes. Diabetes Care (2008) 1.12
Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A (2008) 1.09
Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol (2012) 1.08
Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain (2002) 1.07
Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J Biol Chem (2004) 1.06
Stereocontrolled total synthesis of a polyfunctional carotenoid, peridinin. J Org Chem (2004) 1.06
Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population. Neuroreport (2007) 1.05
Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.05
Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol (2012) 1.05
Nerve excitability testing and its clinical application to neuromuscular diseases. Clin Neurophysiol (2006) 1.04
Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis. J Neurochem (2009) 1.04
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis. J Neurol Sci (2013) 1.04